1. Lee WS, Kim J. Facial nerve palsy and surgical management. J Korean Med Assoc 2009;52:807–18.
3. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996;124:27–30.
4. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 2007;357:1598–607.
5. Holland NJ, Bernstein JM. Bell’s palsy. BMJ Clin Evid 2014;2014:1204
6. Selesnick SH, Patwardhan A. Acute facial palsy: evaluation and early management. Am J Otolaryngol 1994;15:387–408.
7. Sunderland SS. Nerves and nerve injuries. 2nd ed. Edinburgh, Scotland: Churchill Livingston;1978.
8. Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell’s palsy. Laryngoscope 1999;109:1177–88.
9. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, et al. Valacyclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007;28:408–13.
10. Ramsey MJ, DerSimonian R, Holtel MR, Burgess LP. Corticosteroid treatment for idiopathic facial nerve palsy: a meta-analysis. Laryngoscope 2000;110:335–41.
11. MY Kim, J Kim. Early stage steroid treatment for acute facial paralysis in Korea. Korean J Otorhinolaryngol-Head Neck Surg 2016;59:346–52.
12. Berg T, Bylund N, Marsk E, Jonsson L, Kanerva M, Hultcrantz M, et al. The effect of prednisolone on sequelae in Bell’s palsy. Arch Otolaryngol Head Neck Surg 2012;138:445–9.
13. Madhok VB, Gagyor I, Daly F, Somasundara D, Sullivan M, Gammie F, et al. Corticosteroids for Bell’s palsy (idiopathic facialparalysis). Cochrane Database Syst Rev 2016;7:CD001942
14. Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: gastrointestinal and endocrinologic side effects. J Am Acad Dermatol 2017;76:11–6.
16. Engström M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008;7:993–1000.
18. Austin JR, Peskind SP, Austin SG, Rice DH. Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone. Laryngoscope 1993;103:1326–33.
19. Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 2013;149:S1–27.
20. Fujiwara T, Namekawa M, Kuriyama A, Tamaki H. High-dose corticosteroids for adult Bell’s palsy: systematic review and meta-analysis. Otol Neurotol 2019;40:1101–8.
21. Fujiwara T, Sato S. Intratympanic steroids for Bell’s palsy: a randomized controlled trial. Otol Jpn 2020;30:75–81.
22. Inagaki A, Minakata T, Katsumi S, Murakami S. Concurrent treatment with intratympanic dexamethasone for moderate-severe through severe Bell’s palsy. Otol Neurotol 2019;40:e1018–23.
23. Inagaki A, Minakata T, Katsumi S, Murakami S. Concurrent treatment with intratympanic dexamethasone improves facial nerve recovery in Ramsay Hunt syndrome. J Neurol Sci 2020;410:116678
24. Chung JH, Park CW, Lee SH, Kim BS, Cho SH, Kim HY, et al. Intratympanic steroid injection for Bell’s palsy: preliminary randomized controlled study. Otol Neurotol 2014;35:1673–8.
25. Kim SJ, Lee J, Lee HY. Lack of evidence to support the beneficial role of intratympanic dexamethasone injection in acute peripheral facial palsy. Otol Neurotol 2019;40:e1024–9.
26. Pitaro K, Waissbluth S, Daniel SJ. Steroids in pediatric Bell palsy: a systematic review. Otolaryngol Head Neck Surg 2011;145:P246
28. Babl FE, Mackay MT, Borland ML, Herd DW, Kochar A, Hort J, et al. Bell’s palsy in Children (BellPIC): protocol for a multicenter, placebo-controlled randomized trial. BMC Pediatr 2017;17:53
30. Garro A, Nigrovic LE. Managing peripheral facial palsy. Ann Emerg Med 2018;71:618–24.
31. McNamara R, Doyle J, Mc Kay M, Keenan P, Babl FE. Medium term outcome in Bell’s palsy in children. Emerg Med J 2013;30:444–6.
34. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385–92.
36. Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell’s palsy (Idiopathic facial palsy). Cochrane Database Syst Rev 2019;9:CD001869
37. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209
38. Miller CS, Cunningham LL, Lindroth JE, Avdiushko SA. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc 2004;135:1311–8.
40. Perry CM, Faulds D. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996;52:754–72.
41. Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, et al. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2015;(11):CD001869
42. Lee HY, Byun JY, Park MS, Yeo SG. Steroid-antiviral treatment improves the recovery rate in patients with severe Bell’s palsy. Am J Med 2013;126:336–41.
43. Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell’s palsy. Laryngoscope 2007;117:147–56.
45. Turgeon RD, Wilby KJ, Ensom MH. Antiviral treatment of Bell’s palsy based on baseline severity: a systematic review and meta-analysis. Am J Med 2015;128:617–28.
46. Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:2209–13.
49. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010;304:859–66.
50. Seehusen DA, Egitto EA. Antiviral therapy for Bell palsy. Am Fam Physician 2016;93:742–3.
52. Steiner I, Mattan Y. Bell’s palsy and herpes viruses: to (acyclo)vir or not to (acyclo)vir? J Neurol Sci 1999;170:19–23.